0001140361-15-041198.txt : 20151113 0001140361-15-041198.hdr.sgml : 20151113 20151113164954 ACCESSION NUMBER: 0001140361-15-041198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151111 FILED AS OF DATE: 20151113 DATE AS OF CHANGE: 20151113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Labinger Barry CENTRAL INDEX KEY: 0001332456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 151229818 MAIL ADDRESS: STREET 1: 6791 BRENDAN COURT CITY: EDINA STATE: MN ZIP: 55439 4 1 doc1.xml FORM 4 X0306 4 2015-11-11 0 0001367644 Emergent BioSolutions Inc. EBS 0001332456 Labinger Barry 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Biosciences Div. Common Stock 2015-11-11 4 S 0 6564 35.51 D 30229 D Common Stock 2015-11-11 4 M 0 9373 28.09 A 39602 D Common Stock 2015-11-11 4 S 0 9373 35.50 D 30229 D Common Stock 2015-11-11 4 M 0 10095 20.94 A 40324 D Common Stock 2015-11-11 4 S 0 10095 35.50 D 30229 D Common Stock 2015-11-12 4 M 0 10094 20.94 A 40323 D Common Stock 2015-11-12 4 S 0 10094 36 D 30229 D Common Stock 2015-11-11 4 F 0 1671 35.88 D 28558 D Stock Option 28.09 2015-11-11 4 M 0 9373 0 D 2014-03-11 2021-03-10 Common Stock 9373 0 D Stock Option 20.94 2015-11-11 4 M 0 10095 0 D 2013-11-11 2020-11-11 Common Stock 10095 0 D Stock Option 20.94 2015-11-12 4 M 0 10094 0 D 2013-11-11 2020-11-11 Common Stock 10094 0 D Consists of an option granted under the company's stock incentive plan on March 11, 2014. Consists of an option granted under the company's stock incentive plan on November 12, 2013. Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50-$35.59, inclusive. /s/ Eric Burt, attorney-in-fact 2015-11-13